US EditionWill registries replace RCTs for kidney tumour ablation? - Interventional News
Summary by Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Will registries replace RCTs for kidney tumour ablation? - Interventional News
David Breen “Although [real-world registries] seem unsexy, it’s the direction of travel,” said David Breen (Southampton University Hospitals, Southampton, UK), describing the comparative advantages and challenges of randomised controlled trials (RCTs) and real-world registries in providing kidney tumour ablation data. “Let’s talk honestly about RCTs. There are problems,” began Breen, during his talk at the European Conference on Interventional O…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
